“To evaluate the efficacy and safety of hESC therapy on 22 patients with CVA.
All the patients showed improved cognitive skills and regained their functional ability. No severe AEs or SAEs were reported during the study. hESC therapy was well tolerated among all the patients included in the study. “
ReoStem
The future of allogenic stem cells
